SEC Form 4 · accession 0001274877-16-000008
CurAegis Technologies, Inc. · CRGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary A Siconolfi
Director
Period of report
Dec 6, 2016
Accepted (ET)
Dec 8, 2016 · 3:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001063197
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 6, 2016 | C | 250,000 | — | A | 863,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series C Voting Convertible Preferred StockF1,F2 | — | Dec 6, 2016 | C | 250,000 | D | Sep 23, 2011 | Sep 23, 2021 | Common Stock | 250,000 | 0 | D |
| Common Stock Purchase Warrant | $0.25 | Dec 7, 2016 | A | 24,000 | A | Dec 7, 2016 | Dec 7, 2026 | Common Stock | 24,000 | 24,000 | D |
| Convertible Promissory Note | $0.25 | Dec 7, 2016 | A | — | A | Dec 7, 2016 | Dec 7, 2021 | Common Stock | — | — | D |
Explanation of responses
- F1The reporting person converted 250,000 shares of Series C Voting Convertible Preferred Stock, par value $.01 per share, into an equivalent number of shares of Common Stock of the Company, par value $.01 per share, resulting in his acquisition of 250,000 shares of Common Stock of the Company.
- F2The reported securities are included within 250,000 Investment Units purchased by the reporting person on 09/23/2011. Each Investment Unit consists of one (1) share of the Company's Series C Voting Convertible Preferred Stock, par value $.01 per share, initially convertible into an equivalent number of shares of Common Stock of the Company, par value $.01 per share, and a warrant to purchase one-tenth (1/10) of a share of Common Stock exercisable immediately for ten years at an initial exercise price equal to the greater of (i) $.01, or (ii) 80% of the volume weighted average sales price per share of the Company's Common Stock during the ten consecutive trading days immediately preceding the notice of exercise.